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ABSTRACT 
Incubation  of  HeLa  cells  in  the  presence  of  millimolar  concentrations  of 
propionate,  butyrate,  or pentanoate  increases  the  specific activity of CMPosialic 
acid:lactosylceramide  sialyltransferase  7-20-fold  within  24  h.  Longer-chain 
saturated  fatty  acids  or  acetate  are  much  less  effective,  decanoate  showing  no 
induction.  Unsaturated  fatty  acid  analogs  of butyrate  and  other  compounds are 
ineffective.  Only the  three  most  effective compounds also produce characteristic 
smooth  extended  cell  processes  in  HeLa  cells.  Butyrate  (5  mM)  induces  the 
sialyltransferase  after a 4-h lag, producing maximum specific activity by 24 h. The 
amount of sialyl-lactosylceramide, the glycolipid product of the enzyme, increases 
during  that  time  3.5  times  more  than  in  control  cultures.  No  other 
glycosphingolipid enzyme is significantly altered by butyrate exposure. The cellular 
shape changes occur 2-3 h later than the increase of sialyltransferase  activity, and 
both  processes  require  the  continuous  presence  of inducer  and  the  synthesis  of 
RNA and protein but not the synthesis of DNA or the presence of serum. 
Transformation of mammalian  fibroblasts,  which 
occurs spontaneously or after exposure to viruses 
or carcinogens,  gives  rise  to cells  that  are  more 
rounded and compact, have shorter processes, and 
grow without contact inhibition  in  tissue cultures 
(30,  27).  Transformed  cells  are  also  unable  to 
synthesize  the  more  complex  glycosphingolipids 
found in normal cells,  because the activities of the 
corresponding  glycosyltransferases are  decreased 
(2,  5, 8, 21).  Revertants of transformed cells have 
been  isolated  which  exhibit  a  return  of  many 
normal  phenotypic  properties  including  cell 
growth and shape (24, 7). Exposure of transformed 
fibroblasts  to  dibutyryl  cyclic  adenosine-mono- 
phosphate  (cAMP)  or  other  N6-adenine  deriva- 
tives produces a  more normal phenotype, includ- 
ing  more  extended  cell  processes  (16,  18,  19). 
Recently, it has been shown that short-chain fatty 
acids, such as butyrate, can alone produce a dras- 
tic  extension  of cell  processes in  epithelioid  cells 
such as the (transformed) HeLa cell  line (14). 1 It 
was  furthermore  found  that  butyrate  causes  in 
HeLa cells the specific increase of one glycosphin- 
t C. W. Sheu, D. Salomon, J, L. Simmons, T. Sree- 
valsan, and E. Freese, manuscript in preparation. 
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tosylglucosylceramide  (GMs),  and  induces  the 
corresponding  enzyme  activity  CMP-sialic  acid: 
lactosylceramide  sialyltransferase  (13).  This  ef- 
fect provides the unique  opportunity  to study  the 
temporal  relationship  between  enzyme  increase 
and  morphological  alteration.  This  relationship 
has been examined, with inconclusive results, after 
reversion  of  transformed  cells  (22,  8,  6)  or 
quantitative  transformation  of normal  cells  with 
RNA  sarcoma  viruses (23,  15,  28).  In  this  paper 
we  report  on  the  specificity  and  kinetics  of 
sialyltransferase  induction  and  relate  it  to  the 
change in morphology investigated in the following 
paper? 
MATERIALS  AND  METHODS 
Cell Culture 
HeLa  cells,  strain  'R  (Grand  Island  Biological 
Company,  Grand  Island,  N.  Y.),  were  cultured  in 
minimal  essential  Eagle's  medium  supplemented  with 
nonessential  amino  acids  (MEM)  (11)  and  10%  calf 
serum  (Flow  Laboratories,  Inc.,  Rockville, Md.);  this 
will  be  called  "medium."  Cells  were grown  in  plastic 
Petri  dishes  of  150  mm  diameter  (Falcon  Plastics, 
Oxnard, Calif.) in a humidified incubator gassed  with 5% 
COz  in  air  at  37~  In  a  typical  experiment,  dishes 
containing  about  107  cells  were  washed  three times in 
Dulbecco's phosphate-buffered saline (10) without Ca ++ 
and Mg  ++ (PBS) and incubated for 10 min in 2.5 ml (per 
dish)  0.05%  trypsin  in  PBS  at  37~  The  cells were 
suspended  in  medium  and  a  portion,  diluted  in 
physiological saline,  was counted in a Cellozone particle 
counter (Particle Data,  Inc.,  Elmhurst,  Ill.).  Cells were 
then seeded in 150-ram plastic Petri dishes at a density of 
2 ￿  10' cells per cm ~ and incubated at 37~  for 24-36 h. 
To  initiate  the  experiment,  the  growth  medium  was 
aspirated  from  the  dish  and  replaced  with  medium 
containing the desired experimental compound. The cells 
were then incubated for different periods of time, usually 
12 h. At the end of that time, the degree of morphological 
alteration  was  photographically  recorded  with  a  Leitz 
inverted microscope at a magnification of 200. The cells 
were harvested for enzyme assay  and glycolipid analysis 
as follows. The experimental medium was aspirated and 
the cell sheet washed three times with warm (37~  PBS. 
The  cells  were  detached  as  stated  above  for  enzyme 
assays,  or by mechanical scraping for glycolipid analysis, 
immediately suspended  in  10  vol of ice-cold  PBS,  and 
centrifuged  at  200 g  for  3  min  at  4~  The cells  were 
suspended  in (10 ml per original dish)  ice-cold  PBS and 
2 j. L. Simmons and A. Breuer,  manuscript in prepara- 
tion. 
centrifuged again. The cell pellet was maintained on ice 
for early glycolipid extraction and enzyme assay. 
Glycolipid Isolation and Analysis 
Glycosphingolipids  were  isolated  from  washed  cell 
pellets  and  partitioned  into  neutral  and  sialic 
acid-containing classes  as previously described (9). The 
neutral  glycosphingolipids  were  further  purified  by 
saponification  (9)  and  separated  by  thin-layer 
chromatography  on  silica  gel  G  plates  (E.  Merck, 
Darmstadt,  West  Germany)  with  the  solvent  system 
chloroform-m~thanol-water (65:25:4,  vol/vol/vol). The 
glycosphingohpids were detected by spraying the plates 
with 50% ammonium bisulfate and heating at 180"C for 
15  rain.  They  were  identified  by  comparing  their 
migration  to  authentic  standards  and  quantified  by 
densitometric  scanning.  The  ganglioside  fraction  was 
separated  by  thin-layer chromatography  (23),  detected 
with resorcinol reagent, and quantified by densitometric 
scanning as previously described (22). 
Incorporation of radioactively labeled precursors was 
measured in cells grown in either [l-l'C]galactose (1.25 
pCi/ml,  28  mCi/mmol,  International  Chemical  and 
Nuclear  Corp.,  lrvine,  Calif.)  or  N-[acetyl-aH]-o- 
mannosamine  (62.5  /~Ci/ml,  400  pCi/mmol,  Tracer- 
lab,  Waltham,  Mass.)  for 24  h.  The radioactive glyeo- 
sphingolipids  were extracted and separated by thin-layer 
chromatography as above, and the radioactivity in indi- 
vidual glycolipids was detected and  quantitated  with a 
Berthold  chromatogram  radioseanner  (Varian  Associ- 
ates, Walnut Creek, Calif.). 
Assay of CMP-Sialic Acid: 
Lactosylceramide Sialyltransferase 
The  glycolipid  acceptor,  lactosylceramide,  was  ob- 
tained from Mites-Yed~  (Rehovoth, Israel) and the sugar 
nueleotide donor, CMP-[4-1'C]sialic acid (6.5-9.0 mCi/ 
mmol), from New England Nuclear, Boston, Mass. The 
washed  cell pellets were suspended  in 2.5 vol of 0.25 M 
sucrose  containing  0.1%  2-mercaptoethanol  and  dis- 
rupted by freezing and  thawing four times (12). 
The assay  of sialyltransferase activity was  similar to 
that described by  Fishman et al.  (13)  but  modified for 
optimum  results  with  HeLa cell extracts.  The reaction 
mixture contained the following:  5 nmol of lactosylcera- 
mide,  30  nmol  of CMP-[1'C]-NAN,  25  gg  of bovine 
cardiolipin (Applied Science Labs,  Inc., State College, 
Pa.),  1.25 jamol  of sodium-cacodylate buffer (pH  6.8), 
375  pg  of  Cutscum  (Fisher  Scientific Co.,  Fairlawn, 
N.J.), and 300 #g of cell protein in a final volume of 25 
/~1.  For  each  assay  the  same  reaction  mixture  minus 
lactosylceramide was  incubated as a control. The reac- 
tions were terminated after 3 h, at which time the activity 
still increased linearly. 
The reaction products  were  isolated by either of two 
procedures.  The first  procedure, using the separation of 
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Sephadex columns, has been described (12). The second 
procedure  took  advantage  of  the  lipophilic nature  of 
gangliosides  in  acidic  calcium  solutions  (3). To  each 
incubation tube,  1.0 ml of chloroform, 0.5 ml methanol, 
0.3  ml 2% CaCI~,  and  0.15  ml  1.0 M  formic acid were 
added.  After vigorous mixing on a  Vortex mixer (Sci- 
ence  Industries,  Inc.,  Springfield,  Mass.)  and  centri- 
fugation,  the  upper  phase  was  discarded.  The  lower 
phases  were  washed  twice with  1.0  ml of upper  phase 
solvent  and  dried  in  counting  vials.  Recovery of Gu3 
was  over 90%.  Radioactivity was determined  by liquid 
scintillation counting.  Both  procedures  produced  com- 
parable  results  but the second  partitioning method was 
simpler and faster. Activities are reported as picomoles 
of  product  formed  from  the  exogenous  acceptor  per 
milligram protein per hour. 
The reaction product GMs was identified  by its migra- 
tion  on  thin-layer  silica  gel  and  its  degradability  by 
purified  neuraminidase  from  CIostridium perfringens 
(Sigma Chemical Co., St.  Louis, Mo.).  After complete 
digestion (16 h with 0.1 U of enzyme in 0.1 ml of 0.05 M 
sodium-acetate  buffer,  pH  5.0),  all of the radioactivity 
was recovered as sialic acid. 
Chemicals 
Propionic,  butyric,  and  pentanoic  acids  (obtained 
from Sigma Chemical Co,) were prepared as 0.5 M stock 
solutions  in  H~O  titrated  to  pH  7.45 with  sodium 
hydroxide. All other test compounds were added directly 
to MEM plus  10% calf serum, titrated to pH 7.45 with 
sodium hydroxide, and sterilized  by filtration with a 0.45 
~m Nalgene filter unit (Sybron Corp., Rochester, N. Y.). 
Other compounds tested were acetic, hexanoic, octanoic, 
decanoic,  crotonic,  a-aminoisobutyric,  L-~-amino-n- 
butyric, 7-amino-n-butyric, and  salicylic  acids obtained 
from  Sigma.  Also tested  (from  Sigma)  were  n-butyric 
acid  methyl  ester,  n-butanol,  methylparabens,  propyl 
parabens,  and  dimethylsulfoxide,  lsobutyric  acid  was 
obtained from Fisher Scientific Co., and DL-2-aminobu- 
tric acid,  phenethyl alcohol, and phenylacetic acid were 
obtained  from  Eastman  Kodak  Co.,  Rochester,  N.  Y. 
Tetrolic  acid  was  obtained  from  Farchan  Research 
Laboratories, Cleveland, Ohio. Actinomycin D (Calbio- 
chem, San Diego, Calif.) was also utilized. 
RESULTS 
Effect of Butyrate on the 
Glycosphingolipid Composition 
Fig.  1  shows  the  ganglioside  pattern  of  HeLa 
cells  grown  for  24  h  in  normal  medium  and  in 
medium supplemented with butyrate (5 mM). Only 
two  resorcinol-positive  areas  were present  on  the 
chromatogram. The doublet corresponding to GM3 
was  more  intensely  stained  in  the  glycosphingo- 
lipid  extract  of cells exposed  to  butyrate  than  in 
that  of  normal  cells.  The  level  of  the  slower- 
migrating ganglioside, which probably is GDa, was 
unaffected by butyrate.  The two gangliosides were 
further  identified  by  their  sensitivity  to  bacterial 
neuraminidase.  The  ganglioside  extract  isolated 
from  cells grown in the presence of both  butyrate 
(5  mM)  and  small  amounts  of N-[acetyl-3H]-D- 
mannosamine  was  incubated  with  purified  neura- 
minidase  and  the  products  were  separated  on 
thin-layer  plates  (Fig.  2).  The  resorcinol-positive 
material  and  the  radioactivity  migrated  with  the 
sialic acid standard.  Only terminal sialic acids are 
hydrolyzed  under  these  conditions.  The  other 
hydrolysis  product  of  GM3, the  lactosylceramide 
GI-2,  was  also  observed  upon  charring  the  chro- 
matogram.  The  gangliosides  of  untreated  cells 
were similarly identified. 
The glycolipid content of normal  and  butyrate- 
treated  HeLa  cells  is  given  in  Table  I.  Three 
neutral  glycosphingolipids  (the  mono-,  di-,  and 
trihexosylceramide)  and  two  gangliosides  (G~3 
and GD3) were observed in this cell line. When the 
cells were exposed  for  24  h  to  5  mM  butyrate  in 
growth  medium,  the  G~3  content  increased  3.5- 
fold,  the GI-I  content increased  about  70%,  while 
the  slight changes  of the other glycosphingolipids 
were  insignificant.  Although  N-acetylgalac- 
tosaminylgalactosylgalactosylglucosylceramide 
(globoside) is present in many human tissues, none 
was  detected  in  HeLa  cells.  The  cell  extracts 
contained some lipid material that migrated on the 
chromatogram  between  the  globoside  and  G~s 
standards,  but  this  material  was  not  labeled  with 
[l~C]-galactose,  in  contrast  to  the  other  glycos- 
phingolipids. 
The  incorporation  of  radioactive  sugars  into 
different  glycosphingolipids  in  the  presence  and 
absence  of butyrate  is  shown  in  Table  I1.  When 
HeLa  cells were grown  for  24  h  in  medium  con- 
taining  N-[acetyl-3H]-t)-mannosamine,  a  spe- 
cific  precursor  of  sialic  acid,  tritium  incorpora- 
tion  into  G Ms was  6.5  times  greater  in  the  pres- 
ence  of  butyrate  than  in  the  controls  and  the 
amount  of radioactive  material  per  nanomole  of 
G M3  was  twice  as  large.  Tritium  incorporation 
into  GD3  was  similar  for  both  treated  and  un- 
treated  cells.  Butyrate-treated  cells  also  showed 
an  almost  twofold  increase  in  incorporation  of 
[l-l~C]galactose  into  GMs  but  in  this  case  the 
amount  of  radioactive  material  per  nanomole  of 
glycosphingolipid  was  approximately  half  that 
of control cells (Table  II). 
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The  increased  amount  of  GM3  has  been  cor- 
related  with an increase in the specific activity of 
CMP-sialic  acid:lactosyl  ceramide  sialyltransfe- 
rase (briefly called sialyltransferase), as a result of 
HeLa cell exposure to 5 mM butyrate (13).  Fig. 3 
shows  that  the  specific  activity  increased  upon 
butyrate exposure after a  4-h lag,  reaching within 
12 h a level 14 times greater than that of untreated 
cells. The possibility of sialyltransferase activation 
or  inhibition by  some  other  cell  component  was 
excluded  by  a  mixing  experiment  (Table  III). 
Addition of butyrate (5 raM) to the assay mixture 
also did not affect the enzyme activity. 
The  effect  of different  butyrate concentrations 
on enzyme induction, measured 24 h after butyrate 
addition to HeLa, is shown in Fig. 4. Morphologi- 
FIGURE  1  Thin-layer chromatogram of gangliosides  extracted from control and butyrate-treated HeLa 
cells. 24 h after growth  of HeLa cells in normal medium or medium containing 5 mM sodium butyrate, 
gangliosides were extracted from an amount of cells representing 5 mg protein, isolated, chromatographed, 
and stained with resorcinol reagent as described  in Materials and Methods.  Gangliosides are visualized as 
resorcinol-positive  purple bands. Lanes I and 4: gangliosides from control cells; lanes 2 and 5: gangliosides 
from  butyrate-treated cells; lane 3: ganglioside  standards, (A) GMs, (B) GM2 (N-acetylgalactosaminyl-[N- 
acetylneuraminyl]-galactosylglucosylceramide),  (C)  GM1  (galactosyl-N-acetylgalactosaminyl-[N- 
acetylneuraminyl]-galactosylglucosylceramide), (D)  Goa,  (N-acetylneuraminylgalactosyI-N-acetylgalac- 
tosaminyl-[N-acetylneuraminyl]-galactosylglucosylceramide). 
SIMMONS, FISHMAN, FREESE, AND  BRADY  Induction  of Sialyltransferase  417 FIGURE 2  Radioscan  of  thin-layer  chromatogram  of  HeLa-derived  gangliosides  before  and  after 
neuraminidase  treatment.  Gangliosides were  extracted  and  isolated from  HeLa cells grown for 24 h  in 
medium containing sodium butyrate (5 mM) and N-[acetyl-aH]-D-mannosamine (156 #i, 62.5 ~Ci/ml), 
One aliquot was untreated (lane 2, in middle) while another aliquot was  incubated overnight with 0.1  U 
neuraminidase (in 0.2 ml of 0.05  M  sodium acetate and 0.154  M  NaC1, pH 5.0) before chromatography 
(lane 3). Lane 1 contains the designated standards. The chromatogram was then scanned  for radioactivity. 
The left panel is the scan  of lane 2 and the right panel that of lane 3. After the radioactive scan, the lower 
portion  of the chromatogram  was  stained  with  the resorcinol reagent,  and  then the upper  portion  was 
charred as described. 
cal changes were seen in cells exposed to as little as 
0,5 mM butyrate but they were more apparent  at  1 
mM  butyrate  or higher.  To establish  whether  the 
decreased induction of sialyltranferase activity and 
cell shape  changes  was  simply a  matter  of inade- 
quate exposure time, cells were incubated in media 
containing 0.5  mM  or 5  mM  butyrate  for up to 3 
days.  No  further  morphological  changes  or  in- 
crease  in  enzyme  activity  were  seen  beyond  the 
effects apparent  at  20 h. 
The induction of sialyltransferase activity and of 
process  formation  is fully reversible. The specific 
activity of the enzyme decreases to the level found 
in control cells within  16-24 h when the butyrate is 
removed from the medium (Fig. 5); the cells return 
to the normal epithelioid morphology within  18-24 
h.  The  half-life  of the  induced  enzyme is  around 
6-8 h. 
Actinomycin  D  (as  well as  cycloheximide)  has 
been shown to prevent both enzyme induction (13) 
and  morphological alteration (14); Table IV dem- 
onstrates that  it does so at very low concentrations 
at  which  RNA  synthesis  can  just  be  inhibited 
whereas  the  other toxic effects observed at  higher 
actinomycin concentrations  (17) are not yet effec- 
tive. Note that  an actinomycin D concentration of 
TABLE  I 
Glycolipid Composition of HeLa Cells Grown in 
Normal and Butyrate-Supplemented Media 
Glycolipid  Structure  Control  Butyrate 
nrnol/mg cell 
protein 
GI- 1  cer-glc*  0.55  0.95 
GI-2  cer-glc-gal  0.41  0.45 
GI-3  cer-glc-gal-gal  1.85  2.21 
GM8  cer-glc-gaI-NAN  0.49  1.72 
GD8  cer-glc-gal-NAN-NAN  0.23  0.19 
HeLa cells were cultured for 24 h at 37~  in normal and 
sodium  butyrate  (5  mM)-supplemented  media.  Glyco- 
lipids  were  extracted,  isolated,  separated,  and  quanti- 
tared  as  described  in  Materials  and  Methods.  Results 
are the average of two experiments. 
* Abbreviations: cer, ceramide; glc,  glucose;  gal, galac- 
tose; NAN, N-acetylneuraminic acid. 
0.25  ~tg/ml  allowed  the  production  of  some  en- 
zyme  while  no  morphological  alteration  was  ob- 
served. 
Other glycosyltransferases involved in glycolipid 
biosynthesis (12) did not increase in the presence of 
butyrate  (Table V). 
418  THE JOURNAL  OF CELL BIOLOGY - VOLUME  66,  1975 TABLE II 
Incorporation of [x~C]Galactose and N-[Acetyl-SH]-D-Mannosamine into Glycosphingolipids of Normal and 
Butyrate- Treated HeLa Cells 
Control Cells  Butyrate-Treated Cells 
Glycosphingolipid 
t~  C  3  H  1,  C  s  H 
cpm/mg  cpm/nmol  cpm/mg  cpm/nmol  cpm/mg  cpm/nmol  cpm/mg  cprn/nmol 
protein  protein  protein  protein 
GI-I  4,465  8,118  --*  2,165  2,279  -- 
G 1-2  2,938  7,166  --  1,698  3,773  -- 
GI-3  17,128  9,258  --  9,375  4,422  -- 
GMs  3,033  6,190  7,249  14,794  5,681  3,303  47,421  27,570 
Gos  6,957  15,124  14,983  32,572  3,274  8,616  11,646  30,647 
HeLa cells were cultured at 37~  in normal and sodium butyrate (5 mM)-supplemented medium which also contained 
[l-"C]galactose (45 I~M, 1.25 ~Ci/ml) or N-[acetyl-aH]-D-mannosamine (156 ~M, 62.5 tzCi/ml). After 24 h, the cells 
were harvested and the radioactive glycosphingolipids were extracted, separated by thin-layer chromatography, and 
quantitated by radioscanning as described in Materials and Methods. 
* No radioactivity was observed. 
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FIGURE 3  Increase of sialyltransferase activity in HeLa 
cells after exposure to butyrate. At time 0, the medium of 
HeLa  cell cultures was replaced with medium contain- 
ing  5  mM  sodium  butyrate.  At  the  designated  times, 
some  cultures  were  harvested  and  assayed  for  sialyl- 
transferase  activity  as  described  in  Materials  and 
Methods. 
Effect of Cell Cycle lnhibitors on 
Enzyme Induction 
In  order  to  establish  whether  the  increase  of 
sialyltransferase  was  simply  a  result  of  cellular 
TABLE III 
Sialyltransferase Activity in Cell Homogenates of 
Normal and B.utyrate-Treated  HeLa Cells  Assayed 
Separately and Admixed 
Sialyltransferase 
activity 
Homogenate  Difference 
Endog-  + Accep- 
enous  tor 
cpm/2 h 
~g  incubation 
Control  297  46  106  60 
Butyrate-treated  305  153  639  486 
Control  212 
Butyrate-treated  127J  76  308  232 
Expected if no  245 
inhibition 
HeLa  cells  were  grown  for  12  h  in  normal  or  butyrate  (5 
mM)-supplemented media. Cell homogenates were prepared and 
assayed separately and admixed for sialyltransferase activity by 
the  standard  assay  except  that  the  reaction  mixtures  were 
incubated for 2 h. 
arrest  at  a  particular  stage  of the  cell  cycle,  the 
effects of thymidine and Colcemid were examined. 
Cells  incubated  for  24  h  in  medium  containing 3 
mM  thymidine,  and  thus  all arrested  in  S  phase, 
showed  no  altered  morphology  and  no  enzyme 
increase. But when their incubation was continued 
for another 12 h in the presence of thymidine and 5 
mM  butyrate,  their  morphology  was  altered  and 
the  enzyme  had  reached  typical  elevated  levels 
(Table  VI).  When  Colcemid  (0.6  ug/ml)  and 
butyrate  were  added  simultaneously  to  normally 
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FIGURE 4  Effect of butyrate and decanoate on sialyl- 
transferase activity in HeLa cells.  Cells were grown for 
12 h in media containing different concentrations of so- 
dium  butyrate  (O)  or  decanoate  (O),  harvested,  and 
assayed  for  sialyltransferase  activity.  Activity  in  un- 
treated cells was 7 pmol/mg protein/h (  ..... ). 
growing  HeLa  cells,  sialyltransferase  activity  in- 
creased  but no process formation was seen. 
Since  serum  withdrawal  causes  process  forma- 
tion in neuroblastoma cells (27), its effect on HeLa 
cells  was  investigated.  When  these  cells  were 
incubated  for  12  h  in  serum-free  medium,  no 
alteration in morphology or enzyme level was seen 
(Table  VI).  However,  when  the  cells  were  incu- 
bated without serum but with 5 mM butyrate, the 
typical cell processes and the characteristic enzyme 
increase were observed. 
Effects of Lipophilic  Agents on 
Sialyltransferase  Induction  and 
Morphological A herations 
To determine the specificity of sialyltransferase 
induction  and  the correlation  between  this induc- 
tion  and the morphological changes, the effect of 
several other compounds was measured.  As Table 
6O 
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FXGURE 5  Effect of butyratr  removal on sialyltransfer- 
ase activity in HeLa cells.  Cells were grown for  12 h in 
medium containing 5 mM  sodium butyrate. At time 0, 
the  medium  of the  cultures was  replaced  with normal 
medium.  At the designated times, cells were harvested 
and  assayed  for  sialyltransferase activity.  Enzyme  ac- 
tivity in untreated cells was 5.6 pmol/mg protein/h. 
TABLE IV 
Actinomycin D Inhibition of Butyrate-lnduced 
Sialyltransferase Increase and Cell Shape Changes 
Sialylt ransferase Activity 
Actinomycin D  Morphology 
Control  +  Butyrate  (+Butyrate) 
pg/ml  pmol/h/rag  protein 
0  5  46  + 
0.03  --  61  + 
0.06  --  56  + 
0.25  8  28  -- 
0.50  --  3  -- 
HeLa cells were grown for 12 h in normal and butyrate (5 
mM)-supplemented media containing different amounts 
of  actinomycin  D.  The  cells  were  then  analyzed  for 
process formation (+) and sialyltransferase activity. 
VII shows, all fatty acids that produced the typical 
process formation t also caused enzyme induction. 
The absence of enzyme induction with decanoate is 
shown  for  different  decanoate  concentrations  in 
Fig.  4.  The  tight grouping  of the Cs,  C~,  and  C0 
saturated  fatty  acids  as the only compounds  pro- 
ducing  these  effects  is  particularly  noteworthy. 
Acetate  and  octanoate,  ineffective  morphologi- 
cally,  produced  only  small  increases  in  enzyme 
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Activities of  Different Glycosyhransferases in HeLa Cells Grown in Normal and Butyrate-Supptemented Media 
Glycosyltransferase  Reaction  Control  Butyrate 
pmol  /mg  protein h 
Glucosyltransferase*  Cer +  UDP-GIc ~  107:~  104~ 
GI-1  +  UDP 
Galactosyltransferasew  GI-2 +  U DP-Gal ~  154  193 
GI-3 +  UDP 
Sialyltransferase  G1-2 +  CMP-NAN ~  5  6911 
GM3 +  CMP 
Cells were grown for 24 h in normal or sodium-butyrate (5 mM)-supplemented medium, harvested, and the enzymes 
were assayed in cell homogenates. It has been shown previously that UDP-GaI:GI-1 galactosyltransferase activity is 
not increased in butyrate-treated cells (13). 
* Glucosyltransferase activity was assayed by the method of Basu et al (1). 
Glucosyltransferase activities are given in cpm/l.5 h/mg protein. 
w Galactosyltransferase activity was assayed by the method of Kijimoto and Hakomori (21). 
II With saturating concentrations of CMP-NAN, sialyltransferase activity was 220 pmol/mg protein/h in butyrate- 
treated cells. 
TABLE VI 
Effect of Thymidine, Colcemid, and Serum- 
Deprivation on the Induction of Sialyhransferase 
Activity  by Butyrate 
Inhibitor 
Sialyltransferase activity 
Control  Butyrate 
pmol/mg protein/h 
Experiment I 
None  8.2 •  1.6  67.2 •  7.8 
Thymidine  6.5 •  0.9  93.8 •  7.7 
Colcemid  7.5 •  0.8  90.5 •  8.2 
Experiment 2 
None  3.0  62 
Serum-Deprivation  2.0  52 
In  Experiment  1,  HeLa  cells  were  grown  for  24  h  in 
normal  or  3  mM  thymidine-containing media.  Normal 
medium  was  then  replaced  with  normal  or  5  mM 
butyrate-supplemented  medium  containing  either  0.6 
#g/ml Colcemid or no further addition. Cells grown with 
thymidine were maintained in thymidine-containing me- 
dium with and without added butyrate (5 mM). After 12 
h the cells were harvested and the enzyme was assayed. 
Stated activities are averages of two separate determina- 
tions. In Experiment 2, HeLa cells were grown for 12 h in 
normal and serum-free media with and without butyrate 
(5 mM). 
activity  whereas  other  fatty  acids,  including  the 
unsaturated  analogs  of butyrate,  were  ineffective. 
Additional  analogs  of  butyrate  (a-aminoisobu- 
tyric,  L-a-amino-n-butyric,  3,-amino-n-butyric, 
TABLE VII 
Induction of  Sialyltransferase by Chain Fatty Acids 
Fatty acid  Sialyltrans-  Morphology 
(sodium salt)  ferase activity 
pmol/mg 
protein/h 
None  7  - 
Acetate (20 mM)  18  - 
Propionate ( I 0 m M)  63  + 
Butyrate (1 mM)  46  + 
Butyrate (5 mM)  65  + 
Crotonate (2 mM)  0  - 
Tetrolate (2 mM)  3  - 
Pentanoate (5 mM)  48  + 
Hexanoate (5 raM)  7  - 
Octanoate (2 mM)  15  - 
Decanoate (0.9 mM)  7  - 
HeLa cells were grown for 24 h in medium supplemented 
with the above fatty acids (sodium salts). Morphological 
changes were determined microscopically: (+) indicates 
process formation, (-) no process formation. 
DL-2-aminobutyric,  and  isobutyric  acids  as  well 
as  butyric  acid  methylester  and  n-butanol)  were 
tested  (at  concentrations  up  to  5  mM)  for  their 
effect on  morphology  alone  and  were found inef- 
fective. 
Other compounds, some of which were reported 
to cause some morphological alterations (14) x were 
also  tested  for  enzyme  induction  (Table  VIII). 
However,  they did  not  produce  the characteristic 
smooth, elongated processes caused by propionate, 
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Absence of  Sialyltransferase Induction by Other 
Compounds 
Sialyltrans- 
Compound  fcrase  Morphology 
activity 
pmol/mg 
protein/h 
None  9  - 
5 mM butyrate  63  + 
1% DMSO  0  - 
5 mM methylparabens  5  * 
I mM propylparabens  14  * 
5 mM 2-phenylethanol  2  - 
5 mM salicylate  0  - 
5 mM phenylacetate  7  * 
Conditions as in Table VII. 
* Cell processes found which are distinctly shorter, more 
branched,  and  less smooth than  those produced by 
butyrate. 
butyrate,  and  pentanoate,  nor  did  they  induce 
sialyltransferase activity. 
DISCUSSION 
The alteration of glycosphingolipid  biosynthesis by 
butyrate observed earlier (13) was investigated in 
detail.  The  cellular content of GM3  is  increased 
3.5-fold  without significant increase in the  other 
membrane glycosphingolipids. GM3 has been iden- 
tified by its characteristic chromatographic migra- 
tion, its susceptibility to neuraminidase treatment, 
and  by the  incorporation of a  labeled sialic acid 
precursor,  N-acetyl-mannosamine, which  was 
clearly  higher,  per  nanomole of  GM3, than  the 
incorporation into control cells.  Interestingly, the 
incorporation of labeled galactose per nanomole of 
GMs, as well as the other glycosphingolipids, was 
less in the presence of butyrate than in its absence. 
This  effect  could  have  resulted  from  the  more 
extended growth of the control than the butyrate 
exposed  cells  (14),  or  from  a  decreased  sugar 
transport  in  the  presence  of butyrate.  Increased 
sugar  transport  has  been  reported  after  viral 
transformation  of  chick  embryo  (31)  and  baby 
hamster kidney (20) cells.  Sugar transport is also 
higher in growing compared to nongrowing cells. 
The increased synthesis of GM3 results from the 
increase  in  the  specific  activity  of  CMP-sialic 
acid:lactosylceramide sialyltransferase activity in 
cells  incubated in the presence of butyrate. Other 
glycosyltransferases involved in glycolipid biosyn- 
thesis  are  not  elevated?  The  increase  in  sialyl- 
transferase activity appears to be due to induction 
of enzyme synthesis as it is blocked by inhibitors of 
RNA  and protein  synthesis. The  induced sialyl- 
transferase turns over within 16-24 h as indicated 
by the reduction in enzyme activity upon removal 
of butyrate; thus the continued presence of butyr- 
ate is required for enzyme induction. These results 
as  well  as  those  from  experiments in  which  the 
mixture  of  cell  homogenates  from  induced  and 
uninduced  cells  is  used  seem  to  rule  out  the 
possibility  that  butyrate  causes  the  increase  of 
sialyltransferase by the activation of the enzyme or 
the removal of an enzyme inhibitor. 
Butyrate  induces  the  sialyltransferase activity 
and morphological changes in HeLa cells even in 
the absence of serum. In contrast, neuroblastoma 
cells rapidly form cell processes upon removal of 
serum  from  the  medium  by  a  cycloheximide- 
independent process  (29).  Interestingly, butyrate 
can slowly produce cell processes also  in human 
neuroblastoma cells in the presence of serum (26).1 
Butyrate appears to arrest HeLa cells in the G~ 
phase of the cell cycl& and glycolipid biosynthesis 
appears to be maximal during G~ (4). However, the 
arrest of the cell cycle by butyrate does not seem to 
be  the  sole  source  of  elevated  enzyme  levels, 
because cells blocked by thymidine in the S phase 
do  not  show  morphological  or  sialyltransferase 
alterations  but  they  develop  these  characteristic 
alterations when butyrate is also added. Similarly, 
Colcemid-treated cells, blocked in the M phase, do 
not show  any enzyme increase, but the enzyme is 
still  induced  by  butyrate  (although  there  is  no 
evidence of process  formation).  This  result sug- 
gests  that  microtubular  assembly  may  play  an 
essential part in process formation (18,  16, 29). 
It is clear from this work that only the unmodi- 
fied,  straight-chain, saturated fatty acids (C3, C4, 
and C5) are effective  in producing both the type of 
cell  shape  alteration and the  sialyltransferase in- 
duction described  for  butyrate.  The  shorter  and 
longer fatty  acids  are  much less  effective  or  are 
ineffective in enzyme induction and they produce 
no  shape  changes.  The mechanism by which  the 
short-chain fatty acids cause these specific  effects 
is unknown. 
Simmons and Breuer  ~ have shown that process 
elongation of HeLa ceils starts 6  7 h after addition 
s In addition, GMs-sialidase  activity is the same in control 
and  butyrate-treated  HeLa  cells. (J.  Tallman,  P.  H. 
Fishman, and R. C.  Henneberry, unpublished observa- 
tions.) 
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ity  demonstrated  here  begins  earlier,  4  h  after 
butyrate addition. It is therefore possible that the 
change of the glycosphingolipid pattern at the cell 
surface  is  necessary  for  the  development  of cell 
processes. For example, the surface change may be 
required  to  allow cell processes  to  attach  to  the 
surface  of  the  culture  dish,  counteracting  the 
tendency of the  cell surface  to  reduce  its surface 
area. This assumption agrees with the observation 
that,  on  butyrate  removal,  enzyme  activity  de- 
creases  well  before  morphological  reversion  oc- 
curs. 
The  effect  of  butyrate,  and  presumably  of 
propionate and pentanoate, is not limited to HeLa 
cells.  Butyrate-induced morphological alterations 
have  been  observed  with  CHO  cells  (32),  with 
Chang liver, L-132, and Intestine 40 cells (14), and 
with  neuroblastoma cells, x but not mouse  neuro- 
blastoma cells (26). 
Morphological changes were also found associ- 
ated  with  exposure  to  mono-  or  dibutyryl cyclic 
AMP and inhibitors of phosphodiesterase  in Chi- 
nese  hamster  ovary  (16),  transformed  fibroblast 
(19) and neuroblastoma (25) cell lines. In contrast, 
cAMP  or  mono-  or  dibutyryl cyclic  AMP  were 
ineffective in altering the morphology of HeLa cell 
lines  (14)  or  inducing sialyltransferase  activity. ~ 
When  butyrate-treated  and  control  HeLa  cells 
were  acid  extracted  at  4,  8,  12,  and  24  h  after 
butyrate  (5  mM)  addition,  no  difference  in  the 
cAMP  content  per  milligram protein  was  found 
(as kindly measured by Dr. A. Peterkofsky). While 
work  is  being continued in this  area,  we  have at 
this  time  no evidence that  the  butyrate effect  is 
related to cAMP. 
Finally, there  is  a  direct  temporal  correlation 
between changes in cell morphology and glycolipid 
metabolism which may be  relevant to the altered 
glycolipid metabolism observed  in many, but not 
all  transformed  cells  (for  a  recent  review  see 
reference  2).  As  indicated  in  the  introductory 
paragraphs,  previous  studies  with  phenotypic 
revertants  (22,  8,  6)  or  mass  transformation  of 
normal cells with RNA tumor viruses (23,  15, 27) 
have  not clarified this association. Since reduced 
glycolipid  glycosyltransferase  activities  are  ob- 
served in transformed cells with altered glycolipid 
compositions  (2,  5,  8,  21),  the  modulation  of 
sialyltransferase activity (and thus  GMs  levels) in 
' P. H. Fishman, J. L. Simmons, and R. C. Henneberry, 
manuscript in preparation. 
HeLa cells by butyrate may provide a  convenient 
model  to  explore  the  role  of these  complex  car- 
bohydrates in malignant processes. 
Received for publication  15  October  1974,  and in  re. 
vised  form 22 February 1975. 
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